Concepedia

Camelia Spiridon

CS

6

Publications

320

Citations

6

H-Index

2002

Active since

Affiliations

The University of Texas Southwestern Medical Center(Current)

Medical City Dallas Hospital

Camelia Spiridon is an author at The University of Texas Southwestern Medical Center specializing in immunology, medicine, and immunotherapy.

Top concepts

Publications per year

2002–2008

6

Publications

6

Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo.

Camelia Spiridon, Maria Ana Ghetie, Jonathan W. Uhr et al. · PubMed · 2002 · 158 citations

, , +17

A Comparison of the<b><i>in Vitro</i></b>and<b><i>in Vivo</i></b>Activities of IgG and F(ab′)2 Fragments of a Mixture of Three Monoclonal Anti-Her-2 Antibodies

Camelia Spiridon, Sarah E. Guinn, Ellen S. Vitetta · Clinical Cancer Research · 2004 · 86 citations

CD30, a marker to detect the high‐risk kidney transplant recipients

Camelia Spiridon, Afzal Nikaein, Mark Lerman et al. · Clinical Transplantation · 2008 · 29 citations

Pre‐transplant level of soluble CD30 is associated with infection after heart transplantation

Afzal Nikaein, Camelia Spiridon, Judson Hunt et al. · Clinical Transplantation · 2007 · 21 citations

Evaluation of Soluble CD30 as an Immunologic Marker in Heart Transplant Recipients

Camelia Spiridon, Judson Hunt, Michael J. Mack et al. · Transplantation Proceedings · 2006 · 15 citations

, , +11

Rows per page

1–5 of 6